Single Ascending Dose and Multiple Ascending Dose Study of AVR-48

NCT06847698 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety Issues
Tolerability
Pharmacokinetics
Pharmacodynamics

Interventions

DRUG: AVR-48
DRUG: Placebo

Sponsor

AyuVis Research, Inc.

Collaborators

[object Object]